NO168110C - Fremgangsmaate for fremstilling av en steril, ikke betennelses-fremkallende, varmeresistent hyaluronsyrefraksjon - Google Patents

Fremgangsmaate for fremstilling av en steril, ikke betennelses-fremkallende, varmeresistent hyaluronsyrefraksjon

Info

Publication number
NO168110C
NO168110C NO871137A NO871137A NO168110C NO 168110 C NO168110 C NO 168110C NO 871137 A NO871137 A NO 871137A NO 871137 A NO871137 A NO 871137A NO 168110 C NO168110 C NO 168110C
Authority
NO
Norway
Prior art keywords
inflammative
sterile
procedure
preparation
hyaluronic acid
Prior art date
Application number
NO871137A
Other languages
English (en)
Norwegian (no)
Other versions
NO871137L (no
NO871137D0 (no
NO168110B (no
Inventor
Jean Hildesheim
Original Assignee
Int Pharmaceutical Products In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Pharmaceutical Products In filed Critical Int Pharmaceutical Products In
Publication of NO871137D0 publication Critical patent/NO871137D0/no
Publication of NO871137L publication Critical patent/NO871137L/no
Publication of NO168110B publication Critical patent/NO168110B/no
Publication of NO168110C publication Critical patent/NO168110C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO871137A 1986-03-21 1987-03-19 Fremgangsmaate for fremstilling av en steril, ikke betennelses-fremkallende, varmeresistent hyaluronsyrefraksjon NO168110C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84263486A 1986-03-21 1986-03-21

Publications (4)

Publication Number Publication Date
NO871137D0 NO871137D0 (no) 1987-03-19
NO871137L NO871137L (no) 1987-09-22
NO168110B NO168110B (no) 1991-10-07
NO168110C true NO168110C (no) 1992-01-15

Family

ID=25287867

Family Applications (1)

Application Number Title Priority Date Filing Date
NO871137A NO168110C (no) 1986-03-21 1987-03-19 Fremgangsmaate for fremstilling av en steril, ikke betennelses-fremkallende, varmeresistent hyaluronsyrefraksjon

Country Status (8)

Country Link
EP (1) EP0239335A3 (da)
JP (1) JPS62295901A (da)
KR (1) KR910004518B1 (da)
AU (1) AU600257B2 (da)
DK (1) DK144987A (da)
IL (1) IL81945A0 (da)
NO (1) NO168110C (da)
ZA (1) ZA871748B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668116A (en) * 1987-03-19 1997-09-16 Anthropharm Pty. Limited Anti-inflammatory compounds and compositions
CA1327354C (en) * 1987-03-19 1994-03-01 David Cullis-Hill Anti-inflamatory compounds and compositions
US5079236A (en) * 1987-05-27 1992-01-07 Hyal Pharmaceutical Corporation Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
DE69018440T2 (de) * 1989-09-12 1995-08-10 Shiseido Co Ltd Verfahren zur herstellung von hyaluronsäure mit niedrigem molekulargewicht.
IT1247175B (it) * 1991-04-19 1994-12-12 Fidia Spa Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico.
US5621093A (en) * 1995-06-06 1997-04-15 Anika Research, Inc. Steam-sterilizing solid hyaluronic acid
ITMI20082015A1 (it) * 2008-11-13 2010-05-14 Mac Pharma S R L Acido ialuronico a basso contenuto di endotossine e ad elevata capacita' di assorbimento di acqua.
CZ301899B6 (cs) * 2009-03-17 2010-07-21 Contipro C, A.S. Zpusob prípravy derivátu kyseliny hyaluronové pomocí O-acyl-O´-alkylkarbonátu v prítomnosti substituovaného pyridinu
WO2014091980A1 (ja) * 2012-12-10 2014-06-19 三洋化成工業株式会社 ヒアルロン酸組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
IN163192B (da) * 1983-10-11 1988-08-20 Fidia Spa
JPS60149601A (ja) * 1984-01-17 1985-08-07 Q P Corp 純度の向上したヒアルロン酸ナトリウムの製造法
EP0221167A4 (en) * 1985-05-09 1988-08-24 David Cullis-Hill PRODUCTION OF HYALURONIC ACID.
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid

Also Published As

Publication number Publication date
NO871137L (no) 1987-09-22
EP0239335A2 (en) 1987-09-30
JPS62295901A (ja) 1987-12-23
NO871137D0 (no) 1987-03-19
KR910004518B1 (ko) 1991-07-05
DK144987D0 (da) 1987-03-20
IL81945A0 (en) 1987-10-20
ZA871748B (en) 1987-08-31
DK144987A (da) 1987-09-22
EP0239335A3 (en) 1988-07-27
KR870008904A (ko) 1987-10-22
NO168110B (no) 1991-10-07
AU600257B2 (en) 1990-08-09
AU6955887A (en) 1987-09-24

Similar Documents

Publication Publication Date Title
NO871408L (no) Forbedringer ved farmasoeytiske akseptable salter.
NO875082D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer.
NO873598L (no) Kirurgisk protese.
FR2599961B1 (fr) Piece a main medicale a laser.
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
NO871549L (no) Medikament for behandling av oeyenbetennelser.
DK549989D0 (da) Fremgangsmaade til fremstilling af en steril, konserveringsmiddelfri aerosoloploesning
NO168110C (no) Fremgangsmaate for fremstilling av en steril, ikke betennelses-fremkallende, varmeresistent hyaluronsyrefraksjon
NO171909C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO168107C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridiner
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO168654C (no) Fremgangsmaate for polymerisering av 1,3-butadien.
ES2061826T3 (es) Un procedimiento de preparacion de derivados n-2,3-butadienil triaminoalcanos.
NO870866L (no) Fremgangsmÿte for fremstilling av et terapeutisk kombinasjonspreparat.
DK539087D0 (da) 4,5-dihydro- og 4,5,6,7-tetrahydro-pyrazolooe1,5-aaapyrimidiner, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
NO873923D0 (no) Fremgangsmaate for fremstilling av et medisinsk hudpreparat
NO884018D0 (no) Fremgangsmaate for fremstilling av en friradikaladdisjonspolymer.
DK103987D0 (da) Substituerede 1,3,4,9-tetrahydropyranooe3,4-baaindol-l-eddikesyrer, deres fremstilling og anvendelse som laegemidler
DK425287D0 (da) Fremstilling af et farmaceutisk praeparat til behandling af kongestivt hjertesvigt
NO881775L (no) Kondenserte heteroalkylen-kinolinaminer, en fremgangsmaateog mellomprodukter for deres fremstilling samt anvendelseav forbindelsene som medikamenter.
ES2019053A4 (es) Centro quirurgico modular ambulatorio.
IT1276509B1 (it) Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
NO873571D0 (no) Fremgangsmaate for fremstilling av et terapeutisk virksomt preparat.
IT1225262B (it) Metodo per la sensibilizzazione di piccoli animali all'infezione da virus dell'immunodeficienza umana (hiv)